News
6h
TipRanks on MSNElicio announces publication of ELI-002 updated AMPLIFY-201 Phase 1 dataElicio Therapeutics (ELTX) announced the publication of follow-up data from the Phase 1 AMPLIFY-201 study evaluating ELI-002 in the peer-reviewed ...
Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...
Developments announced thecompletion of its Phase I drilling campaign to support the conversion of a portion of its current Indicated ...
The first patient in Cohort 3, the fifth patient in the trial, has completed the first week of cycle 1 following the ...
Successful Phase 1 trial data indicates a 31% confirmed response rate for ALLO-316 in patients with advanced or metastatic renal cell carcinoma (RCC), demonstrating significant clinical potential.
Marvel has finally remembered how to make a movie again like its Phase 1 films with The Fantastic Four: First Steps.
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.
Mailing Address 825 Eastlake Ave. E. Mailstop LG-350 Seattle, WA 98109-1024 In a phase 1 clinical trial, small groups of participants get a new drug, or a combination of several drugs, that has shown ...
The Fantastic Four: First Steps has officially kicked off Phase 6, bringing Marvel's first family into the MCU and in their own universe (Earth-828), separate from the 'main' MCU universe (Earth-616).
OPM and Professor Peyrin-Biroulet, presented the phase 1 results at the United European Gastroenterology Week (UEGW) 2024 held from October 12 to 15, 2024 in Vienna, Austria.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results